» Articles » PMID: 17471040

Experimental Infections with West Nile Virus

Overview
Date 2007 May 2
PMID 17471040
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: West Nile virus emerged recently in North America as a serious human and animal pathogen. This review summarizes the use of experimental infections with West Nile virus in diverse vertebrate species that have been used to answer fundamental questions about the host response, pathogenesis of West Nile virus infection and virus evolution.

Recent Findings: West Nile virus has an extremely broad vertebrate host range. Infection of common species of birds has defined those with high vs. low potential to serve as amplifying hosts for the virus. In general, mammals (primates, horses, companion animals) are dead-end hosts for West Nile virus, although some circumstances (i.e. immunosuppression) may allow individuals to become capable of transmitting the virus to mosquitoes. Some mammals (rodents, rabbits, squirrels) and reptiles (alligators) have been found to develop a viremia of sufficient magnitude to predict at least low competence for infecting feeding mosquitoes. Finally, experimental infection of rodents, horses and primates with West Nile virus has been integral to developing and evaluating the efficacy of West Nile virus vaccines.

Summary: Experimental infection with West Nile virus has assisted in delineating those hosts important and not important to the transmission cycle, in understanding how the virus induces disease in susceptible hosts, and in validating the efficacy of vaccines used for control of disease.

Citing Articles

An Update on the Entomology, Virology, Pathogenesis, and Epidemiology Status of West Nile and Dengue Viruses in Europe (2018-2023).

Frasca F, Sorrentino L, Fracella M, DAuria A, Coratti E, Maddaloni L Trop Med Infect Dis. 2024; 9(7).

PMID: 39058208 PMC: 11281579. DOI: 10.3390/tropicalmed9070166.


Virulence and transmission vary between Usutu virus lineages in Culex pipiens.

Prat M, Jeanneau M, Rakotoarivony I, Duhayon M, Simonin Y, Savini G PLoS Negl Trop Dis. 2024; 18(6):e0012295.

PMID: 38935783 PMC: 11236178. DOI: 10.1371/journal.pntd.0012295.


Vaccination and Control Methods of West Nile Virus Infection in Equids and Humans.

Cendejas P, Goodman A Vaccines (Basel). 2024; 12(5).

PMID: 38793736 PMC: 11125624. DOI: 10.3390/vaccines12050485.


Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches.

Naveed A, Eertink L, Wang D, Li F Viruses. 2024; 16(5).

PMID: 38793662 PMC: 11125849. DOI: 10.3390/v16050781.


Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020-2021 for Respiratory Symptoms.

Underwood E, Vera I, Allen D, Alvior J, ODriscoll M, Silbert S Viruses. 2024; 16(5).

PMID: 38793601 PMC: 11125834. DOI: 10.3390/v16050719.